We harness AI to accelerate drug discovery
We use artificial intelligence (AI) technology to explain the physical and chemical nature of biological systems.
What is our philosophy?
Drug Discovery Pipeline
AI Approach and Solutions
Learn More
Accutar Biotechnology Announces First Patient Dosed with AC0682 in Phase 1 Study in Patients with ER-Positive / HER2-Negative Locally Advanced or Metastatic Breast Cancer
Dec 01, 2021
Read More
Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0682 in ER-Positive Breast Cancer
Sep 20, 2021
Read More
Accutar Biotech Announces Dr. Carlos Garcia-Echeverria, as CEO Advisor
Jul 08, 2021
Read More